Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032

Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032

The global cancer pain management market size is expected to reach USD 8.39 billion by 2032, according to a new study by Polaris Market Research. The report “Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer pain management market is witnessing rapid growth. Cancer pain can range from mild to severe and present in various forms, such as sharp stabbing pain, tingling, burning sensation, or a persistent ache. The impact of cancer pain on your quality of life is significant, worsening cancer symptoms and treatment side effects. Additionally, it can heighten the likelihood of developing depression and anxiety. Therefore, proper pain management is crucial in cancer treatment.

Additionally, cancer care management services focus on optimizing symptom management, including pain control, throughout the cancer journey of the patient. They provide holistic and compassionate care tailored to each patient's unique needs and preferences. Effective cancer pain management requires a collaborative effort from oncologists, pain specialists, cancer care teams, nurses, social workers, and other healthcare professionals to address the complex and individualized needs of cancer patients.

In recent years, additional methods that could be beneficial in alleviating chronic pain include acupuncture. This traditional Chinese medicine practice entails the insertion and manipulation of thin needles into specific areas of the skin. While scientific research has demonstrated the effectiveness of acupuncture in treating certain types of pain, there is limited evidence regarding its efficacy in managing cancer-related pain. Transcutaneous electrical nerve stimulation (TENS) therapy involves the application of a low-level electrical current through electrodes placed on the skin, eliciting a response from the body that helps alleviate pain.

Cancer Pain Management Market Report Highlights

The opioids segment dominated the market, largely attributable to their property to alleviate moderate to severe pain.

The non-opioids drug segment is projected to grow at a CAGR during the projected period, mainly driven by its effectiveness in managing mild to moderate pain.

The lung cancer segment accounted for the largest market share, attributed to the rising prevalence of lung cancer, a higher frequency of pain related to lung cancer.

The hospitals segment dominated the market highly accelerated due to the increasing preference and trust of patients towards hospital settings.

The North America region dominated the market attributed to the increasing prevalence of cancer has created a greater demand for healthcare services.

The global key market players include BioDelivery Sciences, Daiichi Sankyo, Eli Lilly & Company, Endo Pharmaceuticals, Johnson & Johnson Inc., etc.

Polaris Market Research has segmented the cancer pain management market report based on pain type, drug type, cancer type, application, end-use, and region:

Cancer Pain Management, Pain Type Outlook (Revenue - USD Billion, 2019 - 2032)

Acute Pain

Chronic Pain

Cancer Pain Management, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

Opioid

Morphine

Fentanyl

Others

Non-opioids

Non-steroidal anti-inflammatory drug

Acetaminophen

Corticosteroids

Anti-depressants

Anti-anxiety drugs

Anti-convulsant drugs

Nerve Blockers

Cancer Pain Management, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

Lung Cancer

Colorectal cancer

Breast cancer

Prostate cancer

Blood cancer

Others

Cancer Pain Management, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Immunotherapy

Chemotherapy

Radiotherapy

Home Therapy

Others

Cancer Pain Management, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

Hospitals

Cancer Care Clinics

Others

Cancer Pain Management, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Australia

Malaysia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa Show more